Lack of Efficacy of Recombinant Human Thyrotropin Versus Thyroid Hormone Withdrawal for Radioiodine Therapy Imaging in a Patient with Differentiated Thyroid Carcinoma Lung Metastases
- 1 June 2004
- journal article
- case report
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 14 (6), 465-467
- https://doi.org/10.1089/105072504323150804
Abstract
The treatment of lung metastases of thyroid cancer is nearly exclusively limited to the administration of iodine-131. For patients presented with micronodular lesions, the therapeutic response is often excellent, increasing life expectancy. Because of the necessity of multiple iodine-131 treatments in the course of this therapy, and subsequently, the lack of tolerance of hormonal withdrawal, the use of recombinant human thyrotropin (rhTSH) as a method of stimulation could represent an interesting alternative. However, as in the present case, the stimulation by rhTSH can be less effective than hormonal withdrawal, as shown in the posttherapy scan to detect metastatic lesions and thus could be detrimental to the treatment efficiency.Keywords
This publication has 10 references indexed in Scilit:
- Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2003
- Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone WithdrawalJournal of Clinical Endocrinology & Metabolism, 2002
- Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormoneJournal of Endocrinological Investigation, 2002
- Usefulness of Recombinant Human Thyrotropin in the Radiometabolic Treatment of Selected Patients with Thyroid CancerThyroid®, 2001
- Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSHActa Endocrinologica, 2001
- Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2000
- Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating HormoneJournal of Clinical Endocrinology & Metabolism, 1997